Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income.
The company reported worldwide net revenues of $13.92 billion for the September quarter, down 6% on a reported basis, or 5.8% on an operational basis.
Net income, adjusted for special items, was $2.95 per share in Q3, compared to $3.66 per share in the year-ago quarter. On a reported basis, third-quarter profit decreased to $1.79 billion or $1.00 per share from $3.95 billion or $2.21 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be
Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw
DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates
eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and